drugset
drugset / Trial / NCT05158101

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for Stroke

NCT05158101 ↗

Phase 1 Recruiting 15 enrolled The Foundation for Orthopaedics and Regenerative Medicine
NaSingle-groupOpen-labelTreatment

Summary

This trial will study the safety and efficacy of intranasal instillation of cultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes for the treatment of Stroke

Timeline

Start
2022-02-01
Primary completion
2026-02
Completion
2026-02

Drugs

EvaluationDrugModalityDoseRoute
Subject AlloEx Other / unclassified 4 ml Intranasal

Indications

stroke disorder